Home/Filings/3/0001140888-09-000078
3//SEC Filing

BLACK BEAR OFFSHORE MASTER FUND LP 3

Accession 0001140888-09-000078

CIK 0000873303other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 12:59 PM ET

Size

5.0 KB

Accession

0001140888-09-000078

Insider Transaction Report

Form 3
Period: 2009-05-31
Holdings
  • Common Stock

    9,914,211
Footnotes (2)
  • [F1]Black Bear Offshore Master Fund, L.P. ("Filer") disclaims membership in a group with any other person within the meaning of Rule 13d-5(b)(i) and Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended.
  • [F2]Eastbourne Capital Management, L.L.C. is the beneficial owner of more than 10 percent of the outstanding common stock of Avi BioPharma, Inc. Under a Letter Agreement Regarding Board of Director Representation dated as of January 30, 2009, between Eastbourne Capital Management, L.L.C. and Avi BioPharma, Inc., Avi BioPharma, Inc. agreed to take all necessary actions to have one designee of Eastbourne Capital Management, L.L.C. nominated to Avi BioPharma, Inc.'s Board of Directors. Pursuant to this agreement, Dr. Kathleen Behrens currently serves on the Board of Directors of Avi BioPharma, Inc.

Issuer

AVI BIOPHARMA INC

CIK 0000873303

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001275688

Filing Metadata

Form type
3
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 12:59 PM ET
Size
5.0 KB